Bausch Health Companies Inc. BHC Income Statement

Bausch health companies inc. (BHC)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Dec'10	Sep'10	Jun'10	Mar'10	Sep'09	Jun'09
Revenues
Service and other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	19,145	20,249	25,992	8,682	7,690	13,364	6,191	5,880	745	2,879	3,253	3,392	3,255
Total revenues
2,012,000	2,224,000	2,209,000	2,152,000	2,016,000	2,121,000	2,136,000	2,128,000	1,995,000	2,163,000	2,219,000	2,233,000	2,109,000	2,403,000	2,479,000	2,420,000	2,372,000	2,757,700	2,786,800	2,732,400	2,170,100	2,222,500	2,056,200	2,041,100	1,886,200	2,063,800	1,541,700	1,095,700	1,068,400	920,067	884,140	820,090	856,103	652,453	600,584	609,387	565,026	514,564	208,267	238,771	219,635	212,523	193,535
Expenses
Cost of alliance and service revenues
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	532	3,372	3,307	-	-
Selling, general and administrative
633,000	668,000	648,000	651,000	587,000	626,000	614,000	642,000	591,000	639,000	623,000	659,000	661,000	665,000	661,000	671,000	813,000	743,100	697,600	685,500	573,800	524,200	504,100	515,700	482,000	450,300	355,700	257,300	241,900	204,714	188,660	185,440	177,286	148,508	134,801	149,657	139,506	127,752	60,187	45,094	43,513	44,774	49,498
Research and Development Expense (Excluding Acquired in Process Cost)
122,000	114,000	123,000	117,000	117,000	120,000	107,000	94,000	92,000	90,000	81,000	94,000	96,000	93,000	101,000	124,000	103,000	95,500	101,600	81,100	55,800	59,100	59,100	66,500	61,300	59,500	49,000	24,500	23,800	20,213	19,170	17,711	22,006	16,777	17,476	17,764	13,670	18,324	13,766	23,644	12,577	23,202	44,692
Amortization of Intangible Assets Excluding Amortization Allocated to Revenues Cost of Good Sold
436,000	445,000	475,000	488,000	489,000	502,000	658,000	741,000	743,000	775,000	657,000	623,000	635,000	658,000	664,000	673,000	678,000	627,200	679,200	585,400	365,200	313,100	393,100	365,600	355,200	362,000	910,200	303,600	326,200	299,500	218,187	210,570	200,643	192,798	138,027	114,946	112,043	117,660	35,499	33,299	33,300	33,121	21,778
Goodwill impairments
-	-	0	0	-	109,000	0	0	2,213,000	0	312,000	0	0	-	1,049,000	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Asset Impairment Charges
14,000	26,000	33,000	13,000	3,000	134,000	89,000	301,000	44,000	85,000	406,000	85,000	138,000	28,000	148,000	230,000	16,000	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restructuring Charges
4,000	3,000	4,000	4,000	20,000	6,000	3,000	7,000	6,000	10,000	6,000	18,000	18,000	54,000	20,000	20,000	38,000	88,000	75,600	143,400	55,000	44,600	61,700	142,100	133,600	116,300	243,100	53,600	49,000	131,887	42,872	30,004	62,337	36,628	15,874	27,626	17,539	41,430	95,916	2,881	613	2,413	11,367
Acquired in-process research and development costs
-	-	-	-	-	-	-	-	1,000	-	0	1,000	4,000	0	31,000	2,000	1,000	-	95,800	12,300	-	-20,300	19,900	8,400	12,000	24,800	124,000	4,800	0	-	145,300	4,568	-	105,200	0	2,000	2,000	28,000	0	10,242	51,003	-	-
Acquisition-related costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	7,000	9,500	13,900	-	1,600	600	1,500	12,000	8,600	7,900	7,900	52,623	4,605	13,867	7,505	20,090	9,498	1,869	1,507	-	28,037	7,577	-	-	5,596
Legal settlements and related fees
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-53,624	-3,155	-	0	-2,000	-400	-	-38,500	-	-	-	-
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset
-13,000	-10,000	-3,000	-20,000	21,000	-14,000	19,000	6,000	-2,000	-8,000	238,000	49,000	10,000	31,000	-9,000	-7,000	-2,000	45,600	-3,800	-11,700	-7,100	28,800	-4,000	-1,900	-8,900	-4,300	35,000	-3,700	2,200	-6,638	-5,630	7,729	9,839	1,944	6,904	1,752	386	-	-	0	-	-	-
Other Operating Income (Expense), Net
-23,000	-1,399,000	-10,000	-8,000	3,000	16,000	15,000	0	-11,000	-236,000	325,000	19,000	240,000	-93,000	-1,000	46,000	-25,000	-81,800	-30,200	-176,900	-6,100	-	232,000	400	43,300	-79,200	-202,400	-1,100	-4,500	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total expenses
1,764,000	3,300,000	1,880,000	1,895,000	1,729,000	2,096,000	2,019,000	2,373,000	4,276,000	2,485,000	2,181,000	2,058,000	1,898,000	2,253,000	3,342,000	2,339,000	2,306,000	2,591,000	2,339,000	2,390,900	1,599,100	1,617,100	1,372,300	1,686,000	1,529,600	1,840,300	2,433,200	954,200	951,400	1,018,137	854,676	733,280	794,607	658,061	488,226	490,921	490,283	563,516	334,579	189,959	203,268	154,179	182,988
Operating Income (Loss)
248,000	-1,076,000	329,000	257,000	287,000	25,000	117,000	-245,000	-2,281,000	-322,000	38,000	175,000	211,000	150,000	-863,000	81,000	66,000	166,700	447,800	341,500	571,000	605,400	683,900	355,100	356,600	223,500	-891,500	141,500	117,000	-98,070	29,464	86,810	61,496	-5,608	112,358	118,466	74,743	-48,952	-126,312	48,812	16,367	58,344	10,547
Interest income
7,000	3,000	2,000	3,000	4,000	2,000	3,000	3,000	3,000	3,000	3,000	3,000	3,000	2,000	3,000	2,000	1,000	1,500	700	900	900	1,200	800	1,200	1,800	2,600	2,800	1,000	1,600	2,701	1,156	1,020	1,123	1,143	1,052	1,086	803	746	126	234	188	238	251
Interest expense
396,000	391,000	406,000	409,000	406,000	414,000	420,000	435,000	416,000	448,000	459,000	459,000	474,000	467,000	470,000	472,000	427,000	432,300	420,200	412,700	297,800	224,900	258,400	241,200	246,500	262,900	249,300	176,800	155,300	162,919	116,042	100,614	102,025	95,198	87,504	83,073	68,751	53,310	11,218	9,952	9,827	10,998	4,049
Write-down of deferred financing charges
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5,774	-	-	-	-
Gain (Loss) on Extinguishment of Debt
-24,000	-2,000	0	-33,000	-7,000	-44,000	0	-48,000	-27,000	-57,000	-1,000	0	-64,000	0	0	0	0	0	0	0	-20,000	-36,300	0	0	-93,700	-35,400	-8,200	0	-21,400	-17,645	-2,322	0	-133	-3,519	-10,315	-14,748	-8,262	-	-	-	-	-	-
Foreign exchange and other
-13,000	-4,000	9,000	3,000	0	5,000	0	-9,000	27,000	20,000	19,000	39,000	29,000	-45,000	-2,000	12,000	-6,000	-3,500	-34,000	5,600	-71,100	-81,000	-53,000	3,400	-13,400	-5,900	5,100	-10,000	1,400	1,242	-1,603	-4,238	24,299	26,487	-3,590	847	2,807	229	301	667	-623	197	314
Gain on investments, net (Note 23)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,400	2,500	-	0	0	3,900	1,900	76	0	-35	2,059	-11	-140	21,158	1,769	0	-5,005	-392	-155	-	-
Loss before benefit from income taxes
-178,000	-1,470,000	-66,000	-179,000	-122,000	-426,000	-300,000	-734,000	-2,694,000	-804,000	-400,000	-242,000	-295,000	-360,000	-1,332,000	-377,000	-366,000	-267,600	-5,700	-64,700	183,000	551,500	376,700	121,000	4,800	-78,100	-1,141,100	-40,400	-54,800	-274,615	-89,347	-17,057	-13,181	-76,706	11,861	43,736	3,109	-133,700	-147,882	39,369	5,950	47,862	27,790
Loss on auction rate securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-385	-1,617
Gain on disposal of investments
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	466	344
Gain on auction rate security settlement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	22,000
Income Tax Expense (Benefit)
-26,000	47,000	-18,000	-9,000	-74,000	-84,000	51,000	138,000	-115,000	-1,316,000	-1,700,000	-205,000	-924,000	152,000	-113,000	-73,000	7,000	119,000	-57,400	-13,100	84,500	49,600	100,300	-1,000	25,100	-203,100	-169,200	-51,200	-27,300	-185,498	-96,992	4,550	-260	-132,561	-29,001	-12,624	-3,373	-102,570	60,000	5,400	9,100	7,500	3,700
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
-152,000	-1,517,000	-48,000	-170,000	-48,000	-342,000	-351,000	-872,000	-2,579,000	512,000	1,300,000	-37,000	629,000	-512,000	-1,219,000	-304,000	-373,000	-386,600	51,700	-51,600	98,500	501,900	276,400	122,000	-20,300	125,000	-971,900	10,800	-27,500	-	7,645	-	-	-	-	-	-	-	-	33,969	-3,150	40,362	24,090
Net income attributable to noncontrolling interest
0	-1,000	1,000	1,000	4,000	2,000	-1,000	1,000	2,000	-1,000	-1,000	1,000	1,000	3,000	-1,000	-2,000	1,000	-400	2,200	1,400	800	-500	1,000	-3,800	2,300	1,200	1,300	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Net Income (Loss) Available to Common Stockholders, Basic
-152,000	-1,516,000	-49,000	-171,000	-52,000	-344,000	-350,000	-873,000	-2,581,000	513,000	1,301,000	-38,000	628,000	-515,000	-1,218,000	-302,000	-374,000	-386,200	49,500	-53,000	97,700	502,400	275,400	125,800	-22,600	123,800	-973,200	10,800	-27,500	-89,117	7,645	-21,607	-12,921	55,855	40,862	56,360	6,482	-	-207,882	-	-	-	-
(Loss) earnings per share attributable to Bausch Health Companies Inc.
Basic (in dollars per share)
-	-	-	-	-	-	-	-	-7.36	1.46	3.71	-0.11	1.80	-1.49	-3.49	-0.88	-1.08	-1.13	0.14	-0.15	0.29	1.50	0.82	0.38	-0.07	-	-2.92	0.04	-	-	0.03	-0.07	-	0.18	0.13	0.19	0.02	0.02	-1.27	0.21	-0.02	0.25	0.15
Diluted (in dollars per share)
-	-	-	-	-	-	-	-	-7.36	1.46	3.69	-0.11	1.79	-1.49	-3.49	-0.88	-1.08	-1.12	0.14	-0.15	0.28	1.47	0.81	0.37	-0.07	-	-2.92	0.03	-	-	0.02	-0.07	-	0.17	0.13	0.17	0.02	0.02	-1.27	0.21	-0.02	0.25	0.15
Basic and diluted loss per share attributable to Bausch Health Companies Inc. (in usd per share)
-0.43	-	-0.14	-0.49	-0.15	-	-1.00	-2.49	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.09	-	-	-	-0.04	-	-	-	-	-	-	-	-	-	-
Weighted-average common shares
Basic (in shares)
-	-	-	-	-	-	-	-	350,700	350,500	350,400	350,100	349,800	349,800	349,500	345,000	344,900	344,700	344,900	344,400	336,800	336,000	335,400	335,300	334,900	-	333,600	308,100	-	-	304,075	304,816	-	308,743	302,702	303,426	303,749	303,040	163,295	158,510	158,387	158,231	158,224
Diluted (in shares)
-	-	-	-	-	-	-	-	350,700	354,300	352,300	350,100	350,500	349,800	349,500	345,000	344,900	332,000	351,000	344,400	343,400	348,500	341,300	341,300	334,900	-	333,600	314,400	-	-	311,743	304,816	-	317,424	322,783	331,369	332,900	300,531	163,295	161,019	158,387	158,652	158,331
Weighted Average Number of Shares Outstanding, Basic and Diluted
353,400	-	352,400	352,100	351,300	-	351,500	351,300	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	305,800	-	-	-	307,776	-	-	-	-	-	-	-	-	-	-
Cash dividends declared per share (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00	0.09	0.09	0.09	0.09	0.09
Product sales
Revenues
1,986,000	2,198,000	2,180,000	2,122,000	1,989,000	2,098,000	2,108,000	2,100,000	1,965,000	2,133,000	2,186,000	2,200,000	2,076,000	2,368,000	2,443,000	2,389,000	2,336,000	2,722,700	2,748,200	2,695,000	2,126,100	2,177,900	2,022,900	1,994,100	1,851,100	2,031,500	1,506,400	1,063,500	1,038,900	942,001	852,747	742,972	750,880	654,171	570,423	530,035	500,421	488,721	201,372	231,245	212,033	204,291	187,716
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues
505,000	622,000	571,000	580,000	524,000	592,000	573,000	584,000	560,000	637,000	650,000	635,000	584,000	655,000	649,000	648,000	620,000	719,600	634,600	669,900	507,900	558,500	545,800	569,600	504,100	717,400	560,800	283,200	284,900	271,482	216,494	192,928	224,196	181,983	162,568	169,912	169,287	210,648	62,142	63,850	58,955	50,669	50,057
Other revenues
Revenues
26,000	26,000	29,000	30,000	27,000	23,000	28,000	28,000	30,000	30,000	33,000	33,000	33,000	35,000	36,000	31,000	36,000	35,000	38,600	37,400	44,000	44,600	33,300	47,000	35,100	32,300	35,300	32,200	29,500	43,452	12,248	56,869	79,231	-10,400	22,471	65,988	58,414	19,963	6,150	4,647	4,349	4,840	2,564
Cost of goods sold (excluding amortization and impairments of intangible assets) and Cost of other revenues
14,000	13,000	13,000	14,000	13,000	10,000	9,000	10,000	13,000	10,000	9,000	11,000	12,000	10,000	9,000	10,000	10,000	9,900	13,600	15,200	14,300	12,700	15,000	16,000	14,300	14,500	14,400	14,500	15,400	-53,637	13,758	16,839	87,640	-28,070	3,078	3,395	33,945	-	-	-	-	-	-